To include your compound in the COVID-19 Resource Center, submit it here.

Immune modulation therapy: Phase II

Researchers published in the European Journal of Vascular and Endovascular Surgery previously reported results from a U.K.

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE